Immunology

Drug development in many areas of immunology is thriving, with companies expanding their pipelines in cardiometabolic, auto-immune or kidney diseases. Various rare but devastating conditions are also the focus of the industry, with a number of orphan drugs rapidly progressing through clinical development.

Therapeutic Experience

Therapeutic Experience

In-depth Expertise

tranScrip’s expertise covers small molecules as well as monoclonal antibodies, cell therapy, antisense oligo-nucleotides and gene therapy. We are helping our clients seize opportunities and meet their development goals by challenging the current clinical and regulatory paradigms.

We provide strategic expertise, therapeutic experience and operational excellence across the entire product lifecycle.

Case Study

Navigating the Development Path for Novel Immunological Biological Products

Read more

Brochure

Immunology Project Examples

Read more

“Michelle has been essential to the successful MHRA outcome for AndroFeme testosterone cream. Without her expertise, clarity of thought, pragmatic yet creative ability to address complex problems, together with her expansive understanding of the product given the unique circumstances of its Australian origins and her calm approach the multitude of hurdles we have addressed has been gold.

Liz Jenvey (Lawley’s Australian regulatory consultant) and Michelle have worked together seamlessly.

Her dedication and hard work on the AndroFeme project will transform the health outcomes of tens of thousands of women in the UK in the near future and for decades to come.

My sincere thanks Michelle.”

Michael Buckley

Medical Director

Lawley Pharmaceuticals

Contact Us

Our experienced physicians and scientists, together with our regulatory, clinical and commercial experts can support you to maximise the value of your products. Whatever your project requires, we have the expertise to meet your needs.